The design of a pharmaceutically acceptable liposomal formulation of recombinant interleukin-2 (rIL-2) for locoregional anticancer immunotherapy
Koppenhagen, FJ Balemans, LTM Steerenberg, PA Jagmont, TM den Otter, W Storm, G
Koppenhagen, FJ
Balemans, LTM
Steerenberg, PA
Jagmont, TM
den Otter, W
Storm, G
Citations
Altmetric:
Series / Report no.
Open Access
Type
Article
Language
Date of publication
1999
Year of publication
Research Projects
Organizational Units
Journal Issue
Title
The design of a pharmaceutically acceptable liposomal formulation of recombinant interleukin-2 (rIL-2) for locoregional anticancer immunotherapy
Translated Title
Published in
J Liposome Res 1999; 9:313-29